The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches | MyNeuroNews MyNeuroNews, 22 Sep 2019 Objectives: FDA has approved Onabotulinum toxin type A (BoNTA) for prophylactic treatment of chronic migraines.